Molecular Diagnostics
Detection of ctDNA Can Guide Post-Surgical Treatment of Colon Cancer Patients
Circulating tumor DNA (ctDNA) has been shown to be a biomarker that can predict whether, following surgical removal of the tumor, a stage II colon cancer patient can safely forgo chemotherapy without risk of recurrence of the disease More...09 Jun 2022
New Way to Identify Influenza A Virus Could Pave Way for More Sensitive Tests
Because the influenza A virus is constantly changing, or mutating, it can be difficult to detect, treat, and inoculate against. By finding new ways to target specific parts of the influenza A virus that do not change when the virus mutates, more sensitive tests can be created to detect the influenza A virus more easily. More...08 Jun 2022
Blood Test Combines Epigenetics, NGS and Machine Learning for Multi-Cancer Early Detection
A qualitative next-generation sequencing (NGS)-based in vitro diagnostic device that detects DNA methylation markers using cfDNA isolated from human peripheral whole blood enables earlier detection and localization of multiple cancer types. More...07 Jun 2022
Quantitative Diagnostic System Delivers Results in Minutes at True POC Situation
A unique quantitative diagnostic system could offer a highly effective and affordable alternative to the current costly and time-consuming screening and monitoring systems currently available in the market. More...07 Jun 2022
Biodesix’s MRD Test for Solid Tumors to Run on Bio-Rad's Upcoming QX600 ddPCR System
Biodesix, Inc. (Boulder, CO, USA) is developing a new novel minimal residual disease (MRD) test in association with the Memorial Sloan Kettering Cancer Center (MSK, New York, NY, USA) that will utilize the advanced multiplexing QX600 ddPCR System to be launched by Bio-Rad Laboratories (Hercules, CA, USA) later this year. More...07 Jun 2022
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Collection and Transport System
PurSafe Plus®
Urine Chemistry Control
Dropper Urine Chemistry Control
In Other News
Blood Test Enables Early Detection of Oral Cancer
MIS-C Linked to Rare, Immune-Related Variants
Noninvasive Blood Test Predicts Rejection After Heart Transplant
Genome-Wide NIPT Uncovers Additional Findings
Proteomics-based Blood Test May Replace Biopsy for Diagnosis of Liver Disease
Novel Method Uses DNA Droplets for Early Disease Detection
Testing for DNA Shed from Colon Cancers into Bloodstream Guides Chemotherapy After Surgery
Blood Test May Be a Game-Changer for TB Diagnoses and Treatment
Blood Test Detects and Monitors Cell Death to Predict Disease Severity
Non-Invasive Tests for Diagnosing Liver Diseases Could Shape Future Clinical Care
Results of Alzheimer’s Disease Blood Tests Are Skewed by Unrelated Chronic Conditions
Liquid Biopsy Predicts Success of ICI Treatment in Lung Cancer Patients
Lung Cancer Detection Blood Test to Reduce Need for Repeated CT Scanning
Molecular Profiling Identifies High-Risk Subtype of Pediatric Liver Cancer
Roche Develops Monkeypox Virus Detection PCR Tests
POC Critical Illness Test Designed for Early Warning and Patient Triaging
World’s First Biomarker Can Diagnose Parkinson's Disease from Blood Serum Samples
Tear Fluid Collected Using Noninvasive Technique Could Help Diagnose Diseases
Illumina’s Pan-Cancer Companion Diagnostic Enables Targeted Therapy
LumiraDx HbA1c Assay Screens and Identifies Patients at Risk for Developing Diabetes
POC System Could Transform Infectious Disease Management
mRNA Test Screens for Multiple Cancers from Single Blood Sample
A Circulating Antibody Enables Prediction of Crohn’s Disease Long Before Symptoms Appear
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
